Use of alpha 2B or 2B/2C adrenoceptor agonists for the treatment of Alzheimer's or Parkinson's disease

摘要

Use of a selective alpha 2B or selective alpha 2B/2C adrenergic receptor agonist in the manufacture of a medicament for the treatment of a neurodegenerative condition of the brain causing damage to neurons projecting to or from the substantia nigra is disclosed, wherein the neurodegenerative condition is Parkinson's or Alzheimer's disease.